VANCOUVER, BRITISH COLUMBIA: Japan's Pharmaceuticals and Medical Devices Agency reviews RepliCel's pre-clinical, quality, and manufacturing data for its non-bulbar dermal sheath (NBDS) platform
...
VANCOUVER, BRITISH COLUMBIA: Results from both trials will support commercialization initiatives, partner discussions and continued clinical development
...
HALIFAX, NOVA SCOTIA: Data Presented at AACR Annual Meeting 2016 Show Control of Cancer Growth in Advanced Tumors Previously Non-Responsive to Treatment with PD-1 Blockades Alone
...
EDMONTON, ALBERTA: - Ceapro expects to commence clinical program with avenanthramides as anti-inflammatory compound before year end - - Pilot clinical study to develop beta glucan as a cholesterol reducer expected to i ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.